Products

SeekerClaw

AI-native

Like having someone brilliant in your pocket.

seekerclaw.xyz SourceProductivity & Collaboration / AI Personal Assistants

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Beka Egod Zakaidze
No social account linked
Launched
8mo ago
2026-03-17 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@seekerclaw
  • Launched on Product HuntLaunch

    Turn your Android phone into a 24/7 personal AI agent

    Mar 17 · 8mo agoLaunch page

Open Source & Self-Hosting

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2026-02-06

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Public pricing: Open Source (MIT)Raw source text; structured plans are extracted after website capture.

Website snapshots

Indexed 2026-03-17

Key pages

Desktop & mobile archive
seekerclaw.xyz/ Snapshot 2026-11-03

Questions & evidence

How much website traffic does SeekerClaw get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is SeekerClaw and what platforms does it support?
SeekerClaw is catalogued under AI Personal Assistants: Like having someone brilliant in your pocket. Supported platforms: Mobile App.
Is SeekerClaw open source?
SeekerClaw has a public repository (https://github.com/sepivip/SeekerClaw) with its source repository published.Source

Related products in this category

Productivity & Collaboration / AI Personal Assistants

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.